Global IV Solutions Market: Information by Nutrition Type (Peripheral Parenteral Nutrition and Total Parenteral Nutrition), Bag Type (Large Volume Bags and Small Volume Bags), Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins Minerals, Parenteral Lipid Emulsion), End User (Hospitals clinics, Ambulatory Surgical Centers and Home Care) and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2028
Market Highlights
The global IV solutions market is expected to register a CAGR of 7.69% during the forecast period and is expected to hit USD 11,511.2 million by 2028.
Intravenous therapy delivers fluids, medications and nutrition directly into a patient's vein. The intravenous route is commonly used to provide nutrition or for rehydrationtopatients who unable toingest food or water by mouth.
Get Sample Report at https://www.marketresearchfuture.com/sample_request/1235
Growing prevalence of chronic diseases, rapidly growing population prone to dysphagia, and innovations in IV solutions are driving the growth of the IV solutions market. Additionally, rising product launches by major market players are also driving the growth of the IV solutions market. For instance, Otsuka Pharmaceuticals (Japan) launched an ENEFLUID injection, the first peripheral parenteral nutrition solution that containswater-soluble vitamins and fat in addition to glucose, amino acids, and electrolytes in a dual-chamber bag.Similarly, in April 2019, B. Braun Melsungen AG (Germany) announced the launch of its Heparin Sodium Injection, USP, with attached safety needle for subcutaneous and intravenous use in the US.However, stringent government regulationsareposing a challenge for the growth of the market. For example, theUS-based company voluntarily recalled one single lot of Lactated Ringer's Injection, USP, in May 2020. The products were being recalled to the hospital/user level due to the presence of particulate matter identified as iron oxide.
Key Players:
MRFR recognizes the following companies as the key players in the global IV solutions market—Baxter International Inc. (US), Fresenius SE Co. KGaA (Germany),B. Braun Melsungen AG (Germany), ICU Medical, Inc. (US), Pfizer Inc. (US), Grifols S.A. (Spain), Terumo Medical Corporation (Japan), and Amanta Healthcare (India).
Segment Analysis
The global Intravenous (IV) Solution Market has been dividedbased on nutrition type, bag type, nutritional content,and end user. The market, based on nutrition type, has been bifurcatedinto peripheral parenteral nutritionand total parenteral nutrition.
Based on bag type, the IV solutions market has been bifurcated into large volume bags (250 ml)and small volume bags (250 ml).Based on nutritional content, the IV solutions market has been segregated into amino acid solution, vitamins minerals, carbohydrates, parenteral lipid emulsion,and others.On the basis of end user, the market is segregated intohospitals clinics, ambulatory surgical centers,andhome care.
Regional Analysis
The global IV solutions market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America is projectedto hold the largest global market share during the assessment perioddue to the increasing patients with acute or chronic diseases such as cancer, rising populations prone to pharyngitis, and tonsillitis.As per the National Cancer Institute data, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide in 2020, and by 2040, the number of cancer cases per year is projected to rise to 29.5 million, and the number of cancer-related deaths may spike to 16.4 million cases.Additionally, the StatPearls data updated in August 2020 stated that tonsillitis is a common disease and makes up approximately 1.3% of outpatient visits.Nutrition therapy is the treatment of a medical condition, for example, diabetes mellitus, through changes in diet, by adjusting the quantity, quality, and method of nutrient intake. In the US, medical nutrition therapy has a legal definition and is provided by a registered dietician.As per the National Diabetes Statistics Report, 2020, approximately 34.2 million
American shavediabetes, and 88 million American adultshave prediabetes. The IV solutions market in Europe is expected to propel during the assessmentperiod due to rising government initiatives, the rising prevalence of cancer, and the increasing awareness among healthcare providers regarding advanced treatment options.The rapidgrowth of the Asia-Pacific market is due to improving infrastructure and rising per capita income, and government initiatives to improve the quality of healthcare. Chinaand India pose to bea lucrative market for IV solutions due to the growing older population.In addition, the rising prevalence of patients in need of healthcare services at home is also driving the regional market.
Access full report @ https://www.marketresearchfuture.com/reports/intravenous-solution-market-1235
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
